<p>Peptonic Medical AB has announced the completion of its restructuring process, resulting in the company becoming debt-free as of February. Key measures included a 70 percent reduction in unsecured debt through a composition agreement, a directed set-off issue to selected creditors, and a rights issue of approximately SEK 15 million, guaranteed to at least SEK 11 million. The board expects that combined proceeds from these actions, along with sales of the company’s intimate care products, will cover liquidity needs for at least the next twelve months. The company has also streamlined operations, strengthened commercial activities, and plans to further adapt its management structure and critical functions to support future growth. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PEPTONIC Medical AB published the original content used to generate this news brief via Cision (Ref. ID: 20260121:BIT:9364:0) on January 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

Peptonic Medical Emerges Debt-Free After Restructuring and Rights Issue